DL
Therapeutic Areas
Antennova Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ATN-022 | Claudin 18.2 Expressing Tumors | Phase II |
| ATN-037 | Checkpoint Inhibitor-Resistant Tumors | Phase II |
| ATN-101 (Xirestomig) | Immune-responsive and 'Cold' Tumors (e.g., Melanoma, Colorectal Cancer) | Phase I |
| ATN-031 | CD24 Expressing Tumors (e.g., Breast, Ovarian, Lung, Liver Cancers) | Phase I |